Skip to main content
. 2014 Sep 10;5(19):8924–8936. doi: 10.18632/oncotarget.2441

Figure 4. Relative cell survival plot by Guava viability assay of 5 DNMT inhibitors in human lung normal and cancer cells.

Figure 4

(A) FCDR, (B) Decitabine, (C) zebularine, (D) EGCG, (E) RG108. WI38(brown), A549(red), H1299(blue)& H1975(green). (F) Western blot of cleaved Capase3&9 in all four human lung cell lines with or with out demethylation drug treatment. Ctr=untreated control; F=FCDR; D=Decitabine; E=EGCG.